The ACTIV-6 Stakeholder Advisory Committee: a model for virtual engagement in decentralized clinical trials

Abstract Introduction: Engaging patients, caregivers, and other stakeholders to help guide the research process is a cornerstone of patient-centered research. Lived expertise may help ensure the relevance of research questions, promote practices that are satisfactory to research participants, impr...

Full description

Bibliographic Details
Main Authors: Megan E. Hamm, Jonathan Arnold, Josh Denson, Talethia Edwards, Greg Merritt, Matthew McCarthy, Danielle Nelson, Kirk T. Phillips, Florence Thicklin, Andrew Vasey, Kathleen McTigue
Format: Article
Language:English
Published: Cambridge University Press 2023-01-01
Series:Journal of Clinical and Translational Science
Subjects:
Online Access:https://www.cambridge.org/core/product/identifier/S2059866123006714/type/journal_article
_version_ 1797387708607234048
author Megan E. Hamm
Jonathan Arnold
Josh Denson
Talethia Edwards
Greg Merritt
Matthew McCarthy
Danielle Nelson
Kirk T. Phillips
Florence Thicklin
Andrew Vasey
Kathleen McTigue
author_facet Megan E. Hamm
Jonathan Arnold
Josh Denson
Talethia Edwards
Greg Merritt
Matthew McCarthy
Danielle Nelson
Kirk T. Phillips
Florence Thicklin
Andrew Vasey
Kathleen McTigue
author_sort Megan E. Hamm
collection DOAJ
description Abstract Introduction: Engaging patients, caregivers, and other stakeholders to help guide the research process is a cornerstone of patient-centered research. Lived expertise may help ensure the relevance of research questions, promote practices that are satisfactory to research participants, improve transparency, and assist with disseminating findings. Methods: Traditionally engagement has been conducted face-to-face in the local communities in which research operates. Decentralized platform trials pose new challenges for the practice of engagement. We used a remote model for stakeholder engagement, relying on Zoom meetings and blog communications. Results: Here we describe the approach used for research partnership with patients, caregivers, and clinicians in the planning and oversight of the ACTIV-6 trial and the impact of this work. We also present suggestions for future remote engagement. Conclusions: The ACTIV-6 experience may inform proposed strategies for future engagement in decentralized trials.
first_indexed 2024-03-08T22:28:57Z
format Article
id doaj.art-0961350250c84397beb6e3c4276cdecb
institution Directory Open Access Journal
issn 2059-8661
language English
last_indexed 2024-03-08T22:28:57Z
publishDate 2023-01-01
publisher Cambridge University Press
record_format Article
series Journal of Clinical and Translational Science
spelling doaj.art-0961350250c84397beb6e3c4276cdecb2023-12-18T06:40:32ZengCambridge University PressJournal of Clinical and Translational Science2059-86612023-01-01710.1017/cts.2023.671The ACTIV-6 Stakeholder Advisory Committee: a model for virtual engagement in decentralized clinical trialsMegan E. Hamm0https://orcid.org/0000-0002-7842-5290Jonathan Arnold1Josh Denson2Talethia Edwards3Greg Merritt4Matthew McCarthy5Danielle Nelson6Kirk T. Phillips7Florence Thicklin8Andrew Vasey9Kathleen McTigue10Division of General Internal Medicine, University of Pittsburgh, Pittsburgh, PA, USADivision of General Internal Medicine, University of Pittsburgh, Pittsburgh, PA, USASection of Pulmonary, Critical Care, and Environmental Medicine, Tulane University School of Medicine, New Orleans, LA, USAOneFlorida Clinical Research Network, Gainseville, FL, USAPatient Is Partner, LLC, Brighton, MI, USADepartment of Medicine, Weill Cornell Medicine, New York, NY, USADepartment of Community Health and Family Medicine, University of Florida College of Medicine, Gainesville, FL, USADepartment of Epidemiology, University of Iowa, Iowa City, IA, USACAPriCORN Clinical Research Network, Chicago, IL, USADivision of General Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USADivision of General Internal Medicine, University of Pittsburgh, Pittsburgh, PA, USA Abstract Introduction: Engaging patients, caregivers, and other stakeholders to help guide the research process is a cornerstone of patient-centered research. Lived expertise may help ensure the relevance of research questions, promote practices that are satisfactory to research participants, improve transparency, and assist with disseminating findings. Methods: Traditionally engagement has been conducted face-to-face in the local communities in which research operates. Decentralized platform trials pose new challenges for the practice of engagement. We used a remote model for stakeholder engagement, relying on Zoom meetings and blog communications. Results: Here we describe the approach used for research partnership with patients, caregivers, and clinicians in the planning and oversight of the ACTIV-6 trial and the impact of this work. We also present suggestions for future remote engagement. Conclusions: The ACTIV-6 experience may inform proposed strategies for future engagement in decentralized trials. https://www.cambridge.org/core/product/identifier/S2059866123006714/type/journal_articlePatient participationcommunity participationstakeholder participationengagementresearch design
spellingShingle Megan E. Hamm
Jonathan Arnold
Josh Denson
Talethia Edwards
Greg Merritt
Matthew McCarthy
Danielle Nelson
Kirk T. Phillips
Florence Thicklin
Andrew Vasey
Kathleen McTigue
The ACTIV-6 Stakeholder Advisory Committee: a model for virtual engagement in decentralized clinical trials
Journal of Clinical and Translational Science
Patient participation
community participation
stakeholder participation
engagement
research design
title The ACTIV-6 Stakeholder Advisory Committee: a model for virtual engagement in decentralized clinical trials
title_full The ACTIV-6 Stakeholder Advisory Committee: a model for virtual engagement in decentralized clinical trials
title_fullStr The ACTIV-6 Stakeholder Advisory Committee: a model for virtual engagement in decentralized clinical trials
title_full_unstemmed The ACTIV-6 Stakeholder Advisory Committee: a model for virtual engagement in decentralized clinical trials
title_short The ACTIV-6 Stakeholder Advisory Committee: a model for virtual engagement in decentralized clinical trials
title_sort activ 6 stakeholder advisory committee a model for virtual engagement in decentralized clinical trials
topic Patient participation
community participation
stakeholder participation
engagement
research design
url https://www.cambridge.org/core/product/identifier/S2059866123006714/type/journal_article
work_keys_str_mv AT meganehamm theactiv6stakeholderadvisorycommitteeamodelforvirtualengagementindecentralizedclinicaltrials
AT jonathanarnold theactiv6stakeholderadvisorycommitteeamodelforvirtualengagementindecentralizedclinicaltrials
AT joshdenson theactiv6stakeholderadvisorycommitteeamodelforvirtualengagementindecentralizedclinicaltrials
AT talethiaedwards theactiv6stakeholderadvisorycommitteeamodelforvirtualengagementindecentralizedclinicaltrials
AT gregmerritt theactiv6stakeholderadvisorycommitteeamodelforvirtualengagementindecentralizedclinicaltrials
AT matthewmccarthy theactiv6stakeholderadvisorycommitteeamodelforvirtualengagementindecentralizedclinicaltrials
AT daniellenelson theactiv6stakeholderadvisorycommitteeamodelforvirtualengagementindecentralizedclinicaltrials
AT kirktphillips theactiv6stakeholderadvisorycommitteeamodelforvirtualengagementindecentralizedclinicaltrials
AT florencethicklin theactiv6stakeholderadvisorycommitteeamodelforvirtualengagementindecentralizedclinicaltrials
AT andrewvasey theactiv6stakeholderadvisorycommitteeamodelforvirtualengagementindecentralizedclinicaltrials
AT kathleenmctigue theactiv6stakeholderadvisorycommitteeamodelforvirtualengagementindecentralizedclinicaltrials
AT meganehamm activ6stakeholderadvisorycommitteeamodelforvirtualengagementindecentralizedclinicaltrials
AT jonathanarnold activ6stakeholderadvisorycommitteeamodelforvirtualengagementindecentralizedclinicaltrials
AT joshdenson activ6stakeholderadvisorycommitteeamodelforvirtualengagementindecentralizedclinicaltrials
AT talethiaedwards activ6stakeholderadvisorycommitteeamodelforvirtualengagementindecentralizedclinicaltrials
AT gregmerritt activ6stakeholderadvisorycommitteeamodelforvirtualengagementindecentralizedclinicaltrials
AT matthewmccarthy activ6stakeholderadvisorycommitteeamodelforvirtualengagementindecentralizedclinicaltrials
AT daniellenelson activ6stakeholderadvisorycommitteeamodelforvirtualengagementindecentralizedclinicaltrials
AT kirktphillips activ6stakeholderadvisorycommitteeamodelforvirtualengagementindecentralizedclinicaltrials
AT florencethicklin activ6stakeholderadvisorycommitteeamodelforvirtualengagementindecentralizedclinicaltrials
AT andrewvasey activ6stakeholderadvisorycommitteeamodelforvirtualengagementindecentralizedclinicaltrials
AT kathleenmctigue activ6stakeholderadvisorycommitteeamodelforvirtualengagementindecentralizedclinicaltrials